Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2016

Open Access 01-12-2016 | Research article

Extracts of six Rubiaceae species combined with rifampicin have good in vitro synergistic antimycobacterial activity and good anti-inflammatory and antioxidant activities

Authors: Abimbola O. Aro, Jean P. Dzoyem, Jacobus N. Eloff, Lyndy J. McGaw

Published in: BMC Complementary Medicine and Therapies | Issue 1/2016

Login to get access

Abstract

Background

The Rubiaceae family has played a significant role in drug discovery by providing molecules with potential use as templates for the development of therapeutic drugs. This study was designed to study the in vitro synergistic effect of six Rubiaceae species in combination with a known anti-TB drug. The antioxidant and anti-inflammatory activity of these species were also evaluated to investigate additional benefits in antimycobacterial treatment.

Methods

The checkerboard method was used to determine the antimycobacterial synergistic activity of plant extracts combined with rifampicin. The antioxidant activity of extracts was determined by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method. Anti-inflammatory activity via inhibition of nitric oxide (NO) production was performed in LPS-activated RAW 264.7 macrophages using the Griess assay.

Results

Combination of rifampicin with the crude extracts resulted in a 4 to 256-fold increase of activity of extracts. The crude extract of Cremaspora triflora produced the best synergistic effect with rifampicin, with a fractional inhibitory concentration (FIC) index of 0.08 against Mycobacterium aurum. Extracts of Psychotria zombamontana had the best antioxidant activity with an IC50 value of 1.77 μg/mL, lower than the IC50 of trolox and ascorbic acid (5.67 μg/mL and 4.66 μg/mL respectively). All the extracts tested inhibited nitric oxide (NO) production in a concentration dependent manner with the percentage of inhibition varying from 6.73 to 86.27 %.

Conclusion

Some of the Rubiaceae species investigated have substantial in vitro synergistic effects with rifampicin and also good free radical scavenging ability and anti-inflammatory activity. These preliminary results warrant further study on these plants to determine if compounds isolated from these species could lead to the development of bioactive compounds that can potentiate the activity of rifampicin even against resistant mycobacteria.
Literature
1.
go back to reference Van Vuuren S, Viljoen A. Plant-based antimicrobial studies – methods and approaches to study the interaction between natural products. Planta Med. 2011;77:1168–82.CrossRefPubMed Van Vuuren S, Viljoen A. Plant-based antimicrobial studies – methods and approaches to study the interaction between natural products. Planta Med. 2011;77:1168–82.CrossRefPubMed
2.
go back to reference Bergmann JS, Woods GL. In vitro activity of antimicrobial combinations against clinical isolates of susceptible and resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 1998;2(8):621–6.PubMed Bergmann JS, Woods GL. In vitro activity of antimicrobial combinations against clinical isolates of susceptible and resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 1998;2(8):621–6.PubMed
3.
go back to reference Bapela NB, Lall N, Fourie PB, Franzblau SG, Van Rensburg CEJ. Activity of 7-methyljuglone in combination with antituberculous drugs against Mycobacterium tuberculosis. Phytomedicine. 2006;13(9-10):630–5.CrossRefPubMed Bapela NB, Lall N, Fourie PB, Franzblau SG, Van Rensburg CEJ. Activity of 7-methyljuglone in combination with antituberculous drugs against Mycobacterium tuberculosis. Phytomedicine. 2006;13(9-10):630–5.CrossRefPubMed
4.
go back to reference Dye C. Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis. Nat Rev Microbiol. 2009;7:81–7.CrossRefPubMed Dye C. Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis. Nat Rev Microbiol. 2009;7:81–7.CrossRefPubMed
5.
go back to reference Sommer C. Inflammation and healing. In: Mattson CP, editor. Pathophysiology. seventhth ed. London: Lippincott Williams & Wilkins; 2005. p. 387–98. Sommer C. Inflammation and healing. In: Mattson CP, editor. Pathophysiology. seventhth ed. London: Lippincott Williams & Wilkins; 2005. p. 387–98.
6.
go back to reference Reljic R, Stylianou E, Balu S, Ma JK. Cytokine interactions that determine the outcome of mycobacterial infection of macrophages. Cytokine. 2010;51:42–6.CrossRefPubMed Reljic R, Stylianou E, Balu S, Ma JK. Cytokine interactions that determine the outcome of mycobacterial infection of macrophages. Cytokine. 2010;51:42–6.CrossRefPubMed
7.
go back to reference Dzoyem JP, Eloff JN. Anti-inflammatory, anticholinesterase and antioxidant activity of leaf extracts of twelve plants used traditionally to alleviate pain and inflammation in South Africa. J Ethnopharmacol. 2015;160:194–201.CrossRefPubMed Dzoyem JP, Eloff JN. Anti-inflammatory, anticholinesterase and antioxidant activity of leaf extracts of twelve plants used traditionally to alleviate pain and inflammation in South Africa. J Ethnopharmacol. 2015;160:194–201.CrossRefPubMed
8.
go back to reference Costantino L, Albasini A, Rastelli G, Benvenuti S. Activity of polyphenolic crude extracts as scavengers of superoxide radicals and inhibitors of xanthine oxidase. Planta Med. 1992;58:342–4.CrossRefPubMed Costantino L, Albasini A, Rastelli G, Benvenuti S. Activity of polyphenolic crude extracts as scavengers of superoxide radicals and inhibitors of xanthine oxidase. Planta Med. 1992;58:342–4.CrossRefPubMed
9.
go back to reference Bogdan C, Rollinghoff M, Diefenbach A. The role of nitric oxide in innate immunity. Immunol Rev. 2000;173:17–26.CrossRefPubMed Bogdan C, Rollinghoff M, Diefenbach A. The role of nitric oxide in innate immunity. Immunol Rev. 2000;173:17–26.CrossRefPubMed
10.
go back to reference Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109–42.PubMed Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109–42.PubMed
11.
go back to reference Nathan CF, Hibbs Jr JB. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol. 1991;3:65–78.CrossRefPubMed Nathan CF, Hibbs Jr JB. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol. 1991;3:65–78.CrossRefPubMed
12.
go back to reference Taira J, Nanbu H, Ueda K. Nitric oxide-scavenging compounds in Agrimonia pilosa Ledeb on LPS-induced RAW264.7 macrophages. Food Chem. 2009;115:1221–7.CrossRef Taira J, Nanbu H, Ueda K. Nitric oxide-scavenging compounds in Agrimonia pilosa Ledeb on LPS-induced RAW264.7 macrophages. Food Chem. 2009;115:1221–7.CrossRef
13.
go back to reference Lee MH, Lee JM, Jun SH, Lee SH, Kim NW, Lee JH, et al. The anti- inflammatory effects of Pyrolae herba extract through the inhibition of the expression of inducible nitric oxide synthase (iNOS) and NO production. J Ethnopharmacol. 2007;112:49–54.CrossRefPubMed Lee MH, Lee JM, Jun SH, Lee SH, Kim NW, Lee JH, et al. The anti- inflammatory effects of Pyrolae herba extract through the inhibition of the expression of inducible nitric oxide synthase (iNOS) and NO production. J Ethnopharmacol. 2007;112:49–54.CrossRefPubMed
14.
go back to reference Lee CJ, Chen LG, Liang WL, Wanga CC. Anti-inflammatory effects of Punica granatum Linne in vitro and in vivo. Food Chem. 2010;118:315–22.CrossRef Lee CJ, Chen LG, Liang WL, Wanga CC. Anti-inflammatory effects of Punica granatum Linne in vitro and in vivo. Food Chem. 2010;118:315–22.CrossRef
15.
go back to reference Nicholas C, Batra S, Vargo MA, Voss OH, Gavrilin MA, Wewers MD, Guttridge DC, Grotewold E, Doseff AI. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation. J Immunol. 2007;179:7121–7.CrossRefPubMed Nicholas C, Batra S, Vargo MA, Voss OH, Gavrilin MA, Wewers MD, Guttridge DC, Grotewold E, Doseff AI. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation. J Immunol. 2007;179:7121–7.CrossRefPubMed
17.
go back to reference Raza M, Shaheen F, Choudhary MI, Suria A, Rahman UA, Sompong S, Delorenzo RJ. Anticonvulsant activities of the FS-1 subfraction isolated from roots of Delphinium denudatum. Phytother Res. 2001;15:426–30.CrossRefPubMed Raza M, Shaheen F, Choudhary MI, Suria A, Rahman UA, Sompong S, Delorenzo RJ. Anticonvulsant activities of the FS-1 subfraction isolated from roots of Delphinium denudatum. Phytother Res. 2001;15:426–30.CrossRefPubMed
18.
go back to reference Nowakowska Z. A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem. 2007;42:125–37.CrossRefPubMed Nowakowska Z. A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem. 2007;42:125–37.CrossRefPubMed
19.
go back to reference Martins D, Nunez CV. Secondary metabolites from Rubiaceae species. Molecules. 2015;20(7):13422–95.CrossRefPubMed Martins D, Nunez CV. Secondary metabolites from Rubiaceae species. Molecules. 2015;20(7):13422–95.CrossRefPubMed
20.
go back to reference Heitzman ME, Neto CC, Winiarz E, Vaisberg AJ, Hammond GB. “Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae),”. Phytochemistry. 2005;66(1):5–29.CrossRefPubMed Heitzman ME, Neto CC, Winiarz E, Vaisberg AJ, Hammond GB. “Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae),”. Phytochemistry. 2005;66(1):5–29.CrossRefPubMed
21.
go back to reference Martins D, Carrion LL, Ramos DF, Salome KS, da Silva Almeida PE, Barison A, Nunez CV. Triterpenes and the antimycobacterial activity of Duroia macrophylla Huber (Rubiaceae). BioMed Res Int. 2013;2013:605831.CrossRefPubMedPubMedCentral Martins D, Carrion LL, Ramos DF, Salome KS, da Silva Almeida PE, Barison A, Nunez CV. Triterpenes and the antimycobacterial activity of Duroia macrophylla Huber (Rubiaceae). BioMed Res Int. 2013;2013:605831.CrossRefPubMedPubMedCentral
22.
go back to reference Aro AO, Dzoyem JP, Hlokwe TM, Madoroba E, Eloff JN, McGaw LJ. Some South African Rubiaceae tree leaf extracts have antimycobacterial activity against pathogenic and non-pathogenic Mycobacterium species. Phytother Res. 2015;29:1004–10.CrossRefPubMed Aro AO, Dzoyem JP, Hlokwe TM, Madoroba E, Eloff JN, McGaw LJ. Some South African Rubiaceae tree leaf extracts have antimycobacterial activity against pathogenic and non-pathogenic Mycobacterium species. Phytother Res. 2015;29:1004–10.CrossRefPubMed
23.
go back to reference Eloff JN. Which extractant should be used for screening and isolation of antimicrobial components from plants? J Ethnopharmacol. 1998;60:1–8.CrossRefPubMed Eloff JN. Which extractant should be used for screening and isolation of antimicrobial components from plants? J Ethnopharmacol. 1998;60:1–8.CrossRefPubMed
24.
go back to reference Hlokwe TM, van Helden P, Michel A. Evaluation of the discriminatory power of variable number of tandem repeat typing of Mycobacterium bovis isolates from southern Africa. Transbound Emerg Dis. 2013;60:111–20.CrossRefPubMed Hlokwe TM, van Helden P, Michel A. Evaluation of the discriminatory power of variable number of tandem repeat typing of Mycobacterium bovis isolates from southern Africa. Transbound Emerg Dis. 2013;60:111–20.CrossRefPubMed
25.
go back to reference Schelz Z, Molnar J, Hohmann J. Antimicrobial and antiplasmid activities of essential oils. Fitoterapia. 2006;77:279–85.CrossRefPubMed Schelz Z, Molnar J, Hohmann J. Antimicrobial and antiplasmid activities of essential oils. Fitoterapia. 2006;77:279–85.CrossRefPubMed
26.
go back to reference Omisore NOA, Adewunmi CO, Iwalewa EO, Ngadjui BT, Adenowo TK, Abegaz BM, Ojewole JA, Watchueng J. Antitrichomonal and antioxi- dant activities of Dorstenia barteri and Dorstenia convexa. Braz J Med Biol Res. 2005;38:1087–94.CrossRefPubMed Omisore NOA, Adewunmi CO, Iwalewa EO, Ngadjui BT, Adenowo TK, Abegaz BM, Ojewole JA, Watchueng J. Antitrichomonal and antioxi- dant activities of Dorstenia barteri and Dorstenia convexa. Braz J Med Biol Res. 2005;38:1087–94.CrossRefPubMed
27.
go back to reference Kuete V, Efferth T. Cameroonian medicinal plants: pharmacology and derived natural products. Front Pharmacol. 2010;1:1–19.CrossRef Kuete V, Efferth T. Cameroonian medicinal plants: pharmacology and derived natural products. Front Pharmacol. 2010;1:1–19.CrossRef
28.
go back to reference Mitchison DA. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis. 1998;2:10–5.PubMed Mitchison DA. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis. 1998;2:10–5.PubMed
29.
go back to reference Wagner H, Ulrich-merzenich G. Synergy research : approaching a new generation of Phytopharmaceuticals. Phytomedicine. 2009;16:97–110.CrossRefPubMed Wagner H, Ulrich-merzenich G. Synergy research : approaching a new generation of Phytopharmaceuticals. Phytomedicine. 2009;16:97–110.CrossRefPubMed
30.
go back to reference Velioglu YS, Mazza G, Gao L, Oomah BD. Antioxidant activity and total phenolics in selected fruits, vegetables, and grain products. J Agric Food Chem. 1998;46:4113–7.CrossRef Velioglu YS, Mazza G, Gao L, Oomah BD. Antioxidant activity and total phenolics in selected fruits, vegetables, and grain products. J Agric Food Chem. 1998;46:4113–7.CrossRef
31.
go back to reference Salomão K, Pereira PR, Campos LC, Borba CM, Cabello PH, Marcucci MC, de Castro SL. Brazilian propolis: correlation between chemical composition and antimicrobial activity. Evid Based Complement Alternat Med. 2008;5(3):317–24.CrossRefPubMed Salomão K, Pereira PR, Campos LC, Borba CM, Cabello PH, Marcucci MC, de Castro SL. Brazilian propolis: correlation between chemical composition and antimicrobial activity. Evid Based Complement Alternat Med. 2008;5(3):317–24.CrossRefPubMed
32.
go back to reference Cushnie TP, Lamb AJ. Recent advances in understanding the antibacterial properties of flavonoids. Int J Antimicrob Agents. 2011;38(2):99–107.CrossRefPubMed Cushnie TP, Lamb AJ. Recent advances in understanding the antibacterial properties of flavonoids. Int J Antimicrob Agents. 2011;38(2):99–107.CrossRefPubMed
33.
go back to reference Chinsamy M, Finnie JF, Van Staden J. Anti-inflammatory, antioxidant, anti- cholinesterase activity and mutagenicity of South African medicinal orchids. S Afr J Bot. 2014;91:88–98.CrossRef Chinsamy M, Finnie JF, Van Staden J. Anti-inflammatory, antioxidant, anti- cholinesterase activity and mutagenicity of South African medicinal orchids. S Afr J Bot. 2014;91:88–98.CrossRef
34.
35.
go back to reference Ryu JH, Ahn H, Kim JY, Kim YK. Inhibitory activity of plant extracts on nitric oxide synthesis in LPS-activated macrophages. Phytother Res. 2003;17:485–9.CrossRefPubMed Ryu JH, Ahn H, Kim JY, Kim YK. Inhibitory activity of plant extracts on nitric oxide synthesis in LPS-activated macrophages. Phytother Res. 2003;17:485–9.CrossRefPubMed
36.
go back to reference Son HJ, Lee HJ, Yun-Choi HS, Ryu JH. Inhibitors of nitric oxide synthesis and TNF-α expression from Magnolia obovata in activated macrophages. Planta Med. 2000;66:469–71.CrossRefPubMed Son HJ, Lee HJ, Yun-Choi HS, Ryu JH. Inhibitors of nitric oxide synthesis and TNF-α expression from Magnolia obovata in activated macrophages. Planta Med. 2000;66:469–71.CrossRefPubMed
37.
go back to reference Ge F, Zeng F, Liu S, Guo N, Ye H, Song Y, et al. In vitro synergistic activity between 8-methoxypsoralen and ethambutol, isoniazid, and rifampin when used in combination against Mycobacterium tuberculosis. World J Microbiol Biotechnol. 2010;26(4):623–8.CrossRef Ge F, Zeng F, Liu S, Guo N, Ye H, Song Y, et al. In vitro synergistic activity between 8-methoxypsoralen and ethambutol, isoniazid, and rifampin when used in combination against Mycobacterium tuberculosis. World J Microbiol Biotechnol. 2010;26(4):623–8.CrossRef
38.
go back to reference Lopes MA, Ferracioli KRC, Siqueira VLD, de Lima Scodro RB, Cortez DAG, da Silva RZ, Cardoso RF. In vitro interaction of eupomatenoid-5 from Piper solmsianum C. DC. var. solmsianum and anti-tuberculosis drugs. Int J Tuberc Lung Dis. 2014;18(12):1513–5.CrossRefPubMed Lopes MA, Ferracioli KRC, Siqueira VLD, de Lima Scodro RB, Cortez DAG, da Silva RZ, Cardoso RF. In vitro interaction of eupomatenoid-5 from Piper solmsianum C. DC. var. solmsianum and anti-tuberculosis drugs. Int J Tuberc Lung Dis. 2014;18(12):1513–5.CrossRefPubMed
Metadata
Title
Extracts of six Rubiaceae species combined with rifampicin have good in vitro synergistic antimycobacterial activity and good anti-inflammatory and antioxidant activities
Authors
Abimbola O. Aro
Jean P. Dzoyem
Jacobus N. Eloff
Lyndy J. McGaw
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2016
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-016-1355-y

Other articles of this Issue 1/2016

BMC Complementary Medicine and Therapies 1/2016 Go to the issue